Manejo de estertores de agonía en la miastenia gravis. A propósito de un caso tratado con octreótrido

The management of death rattle in patients with terminal myasthenia gravis can be quite complex. Drugs regularly employed to reduce disturbing noisy respiratory secretions (hyoscine hydrobromide, hyoscine butylbromide, etc.) could trigger a myasthenia crisis due to their anti -cholinergic effects. We report a case treated by our team with octreotide, and discuss potential indications in this setting.